[Alprostadil combined with antithrombotic drugs. Effects on hemorrhage time].
Minciotti
A
A
Dipartimento di Medicina Interna, Università degli Studi, Perugia.
Goracci
S
S
Nenci
G G
GG
D000527:Alprostadil / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006470:Hemorrhage / Q000139:chemically induced*; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D012307:Risk Factors; D013997:Time Factors
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D000527:Alprostadil